HEADER RECEPTOR 09-MAY-08 2VT4 TITLE TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND TITLE 2 CYANOPINDOLOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA1 ADRENERGIC RECEPTOR; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 33-243,272-276,279-367; COMPND 5 SYNONYM: BETA-1 ADRENOCEPTOR, BETA-1 ADRENORECEPTOR, BETA-T; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MELEAGRIS GALLOPAVO; SOURCE 3 ORGANISM_COMMON: COMMON TURKEY; SOURCE 4 ORGANISM_TAXID: 9103; SOURCE 5 CELL: ERYTHROCYTE; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBACPAK8 KEYWDS GPCR, MEMBRANE, RECEPTOR, PALMITATE, TRANSDUCER, ANTAGONIST BOUND KEYWDS 2 FORM, INTEGRAL MEMBRANE PROTEIN, G-PROTEIN COUPLED RECEPTOR, G KEYWDS 3 PROTEIN COUPLED RECEPTOR, THERMOSTABILISING POINT MUTATIONS, KEYWDS 4 PHOSPHOPROTEIN, SEVEN-HELIX RECEPTOR, LIPOPROTEIN, 7TM RECEPTOR, KEYWDS 5 GLYCOPROTEIN, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR A.WARNE,M.J.SERRANO-VEGA,J.G.BAKER,R.MOUKHAMETZIANOV,P.C.EDWARDS, AUTHOR 2 R.HENDERSON,A.G.W.LESLIE,C.G.TATE,G.F.X.SCHERTLER REVDAT 8 13-DEC-23 2VT4 1 HETSYN REVDAT 7 29-JUL-20 2VT4 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE REVDAT 6 03-APR-19 2VT4 1 SOURCE REVDAT 5 06-MAR-19 2VT4 1 REMARK REVDAT 4 30-JAN-13 2VT4 1 JRNL REMARK VERSN FORMUL REVDAT 3 24-FEB-09 2VT4 1 VERSN REVDAT 2 29-JUL-08 2VT4 1 SOURCE JRNL REVDAT 1 24-JUN-08 2VT4 0 JRNL AUTH A.WARNE,M.J.SERRANO-VEGA,J.G.BAKER,R.MOUKHAMETZIANOV, JRNL AUTH 2 P.C.EDWARDS,R.HENDERSON,A.G.W.LESLIE,C.G.TATE, JRNL AUTH 3 G.F.X.SCHERTLER JRNL TITL STRUCTURE OF A BETA1-ADRENERGIC G-PROTEIN-COUPLED RECEPTOR. JRNL REF NATURE V. 454 486 2008 JRNL REFN ISSN 0028-0836 JRNL PMID 18594507 JRNL DOI 10.1038/NATURE07101 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.J.SERRANO-VEGA,F.MAGNANI,Y.SHIBATA,C.G.TATE REMARK 1 TITL CONFORMATIONAL THERMOSTABILISATION OF THE BETA1-ADRENERGIC REMARK 1 TITL 2 RECEPTOR IN A DETERGENT RESISTANT FORM REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 105 877 2008 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 18192400 REMARK 1 DOI 10.1073/PNAS.0711253105 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.PHASER) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.10 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 41499 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2047 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 52.82 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.370 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.87470 REMARK 3 B22 (A**2) : 8.78930 REMARK 3 B33 (A**2) : -3.91460 REMARK 3 B12 (A**2) : 0.49510 REMARK 3 B13 (A**2) : 0.40510 REMARK 3 B23 (A**2) : -2.39760 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 9180 REMARK 3 ANGLE : 1.272 12460 REMARK 3 CHIRALITY : 0.078 1451 REMARK 3 PLANARITY : 0.005 1453 REMARK 3 DIHEDRAL : 26.761 3384 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRICT NCS, SIGMA 0.025, APPLIED TO REMARK 3 CHAINS A AND D AND TO CHAINS B AND C, EXCLUDING DETERGENTS REMARK 4 REMARK 4 2VT4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1290035931. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41499 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 46.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 2RH1 REMARK 200 REMARK 200 REMARK: THE LYSOZYME COMPONENT OF 2RH1 WAS REMOVED FOR THE REMARK 200 MOLECULAR REPLACEMENT REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION. EQUAL VOLUMES OF REMARK 280 PROTEIN (6MG/ML) IN 10MM TRIS-HCL PH7.7, 50MM NACL, 0.1MM EDTA, REMARK 280 0.35% OCTYLTHIOGLUCOSIDE, 0.5MM CYANOPINDOLOL AND RESERVOIR 0.1M REMARK 280 ADA, PH 6.9-7.3, 29-32% PEG600., PH 7.1, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 358 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 358 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN C, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN C, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN C, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN C, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN C, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN C, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN C, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN C, CYS 358 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN D, ARG 68 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN D, MET 90 TO VAL REMARK 400 ENGINEERED RESIDUE IN CHAIN D, CYS 116 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN D, TYR 227 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN D, ALA 282 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN D, PHE 327 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN D, PHE 338 TO MET REMARK 400 ENGINEERED RESIDUE IN CHAIN D, CYS 358 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 31 REMARK 465 GLY A 32 REMARK 465 ALA A 33 REMARK 465 GLU A 34 REMARK 465 LEU A 35 REMARK 465 LEU A 36 REMARK 465 SER A 37 REMARK 465 GLN A 38 REMARK 465 GLN A 39 REMARK 465 ARG A 239 REMARK 465 LYS A 240 REMARK 465 ILE A 241 REMARK 465 ASP A 242 REMARK 465 ARG A 243 REMARK 465 ALA A 272 REMARK 465 SER A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 LYS A 276 REMARK 465 ARG A 279 REMARK 465 VAL A 280 REMARK 465 MET A 281 REMARK 465 LEU A 282 REMARK 465 MET A 283 REMARK 465 PHE A 359 REMARK 465 PRO A 360 REMARK 465 ARG A 361 REMARK 465 LYS A 362 REMARK 465 ALA A 363 REMARK 465 ASP A 364 REMARK 465 ARG A 365 REMARK 465 ARG A 366 REMARK 465 LEU A 367 REMARK 465 HIS A 368 REMARK 465 HIS A 369 REMARK 465 HIS A 370 REMARK 465 HIS A 371 REMARK 465 HIS A 372 REMARK 465 HIS A 373 REMARK 465 MET B 31 REMARK 465 GLY B 32 REMARK 465 ALA B 33 REMARK 465 GLU B 34 REMARK 465 LEU B 35 REMARK 465 LEU B 36 REMARK 465 SER B 37 REMARK 465 GLN B 38 REMARK 465 ARG B 239 REMARK 465 LYS B 240 REMARK 465 ILE B 241 REMARK 465 ASP B 242 REMARK 465 ARG B 243 REMARK 465 ALA B 272 REMARK 465 SER B 273 REMARK 465 LYS B 274 REMARK 465 ARG B 275 REMARK 465 LYS B 276 REMARK 465 ARG B 279 REMARK 465 VAL B 280 REMARK 465 MET B 281 REMARK 465 LEU B 282 REMARK 465 MET B 283 REMARK 465 PRO B 360 REMARK 465 ARG B 361 REMARK 465 LYS B 362 REMARK 465 ALA B 363 REMARK 465 ASP B 364 REMARK 465 ARG B 365 REMARK 465 ARG B 366 REMARK 465 LEU B 367 REMARK 465 HIS B 368 REMARK 465 HIS B 369 REMARK 465 HIS B 370 REMARK 465 HIS B 371 REMARK 465 HIS B 372 REMARK 465 HIS B 373 REMARK 465 MET C 31 REMARK 465 GLY C 32 REMARK 465 ALA C 33 REMARK 465 GLU C 34 REMARK 465 LEU C 35 REMARK 465 LEU C 36 REMARK 465 SER C 37 REMARK 465 GLN C 38 REMARK 465 ARG C 239 REMARK 465 LYS C 240 REMARK 465 ILE C 241 REMARK 465 ASP C 242 REMARK 465 ARG C 243 REMARK 465 ALA C 272 REMARK 465 SER C 273 REMARK 465 LYS C 274 REMARK 465 ARG C 275 REMARK 465 LYS C 276 REMARK 465 ARG C 279 REMARK 465 VAL C 280 REMARK 465 MET C 281 REMARK 465 LEU C 282 REMARK 465 MET C 283 REMARK 465 PRO C 347 REMARK 465 ASP C 348 REMARK 465 PHE C 349 REMARK 465 ARG C 350 REMARK 465 LYS C 351 REMARK 465 ALA C 352 REMARK 465 PHE C 353 REMARK 465 LYS C 354 REMARK 465 ARG C 355 REMARK 465 LEU C 356 REMARK 465 LEU C 357 REMARK 465 ALA C 358 REMARK 465 PHE C 359 REMARK 465 PRO C 360 REMARK 465 ARG C 361 REMARK 465 LYS C 362 REMARK 465 ALA C 363 REMARK 465 ASP C 364 REMARK 465 ARG C 365 REMARK 465 ARG C 366 REMARK 465 LEU C 367 REMARK 465 HIS C 368 REMARK 465 HIS C 369 REMARK 465 HIS C 370 REMARK 465 HIS C 371 REMARK 465 HIS C 372 REMARK 465 HIS C 373 REMARK 465 MET D 31 REMARK 465 GLY D 32 REMARK 465 ALA D 33 REMARK 465 GLU D 34 REMARK 465 LEU D 35 REMARK 465 LEU D 36 REMARK 465 SER D 37 REMARK 465 GLN D 38 REMARK 465 GLN D 39 REMARK 465 TRP D 40 REMARK 465 ARG D 239 REMARK 465 LYS D 240 REMARK 465 ILE D 241 REMARK 465 ASP D 242 REMARK 465 ARG D 243 REMARK 465 ALA D 272 REMARK 465 SER D 273 REMARK 465 LYS D 274 REMARK 465 ARG D 275 REMARK 465 LYS D 276 REMARK 465 ARG D 279 REMARK 465 VAL D 280 REMARK 465 MET D 281 REMARK 465 LEU D 282 REMARK 465 MET D 283 REMARK 465 ALA D 358 REMARK 465 PHE D 359 REMARK 465 PRO D 360 REMARK 465 ARG D 361 REMARK 465 LYS D 362 REMARK 465 ALA D 363 REMARK 465 ASP D 364 REMARK 465 ARG D 365 REMARK 465 ARG D 366 REMARK 465 LEU D 367 REMARK 465 HIS D 368 REMARK 465 HIS D 369 REMARK 465 HIS D 370 REMARK 465 HIS D 371 REMARK 465 HIS D 372 REMARK 465 HIS D 373 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 133 CB CYS A 133 SG -0.103 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 68 -79.50 -102.49 REMARK 500 THR A 69 100.18 -53.42 REMARK 500 SER A 145 50.67 -151.49 REMARK 500 SER A 173 -53.73 -120.42 REMARK 500 PHE A 216 -65.39 -125.04 REMARK 500 GLU A 236 -5.61 -43.57 REMARK 500 LEU A 357 37.06 -99.95 REMARK 500 SER B 68 -74.18 -77.68 REMARK 500 ASP B 186 134.34 -38.91 REMARK 500 PHE B 216 -56.47 -129.69 REMARK 500 PHE B 225 -70.82 -55.07 REMARK 500 GLU B 236 3.19 -64.60 REMARK 500 ALA B 358 90.95 58.96 REMARK 500 SER C 68 -74.03 -77.75 REMARK 500 ASP C 186 134.50 -39.67 REMARK 500 PHE C 216 -57.24 -129.83 REMARK 500 PHE C 225 -71.19 -53.99 REMARK 500 GLU C 236 2.97 -64.29 REMARK 500 SER C 336 -9.81 -59.62 REMARK 500 SER D 68 -79.34 -102.79 REMARK 500 THR D 69 99.86 -53.34 REMARK 500 SER D 145 49.95 -152.20 REMARK 500 SER D 173 -54.33 -121.60 REMARK 500 PHE D 216 -65.61 -124.45 REMARK 500 LYS D 235 -72.63 -75.75 REMARK 500 GLU D 236 -3.81 -57.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 SOG B 404 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 192 O REMARK 620 2 ASP A 195 O 78.9 REMARK 620 3 CYS A 198 O 98.4 88.1 REMARK 620 4 HOH A2002 O 117.1 148.3 114.3 REMARK 620 5 HOH A2006 O 164.4 90.4 69.7 77.8 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 195 O REMARK 620 2 CYS B 198 O 84.1 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA C 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 195 O REMARK 620 2 CYS C 198 O 84.5 REMARK 620 3 HOH C2005 O 85.5 67.5 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA D 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS D 192 O REMARK 620 2 ASP D 195 O 79.2 REMARK 620 3 CYS D 198 O 98.8 88.4 REMARK 620 4 HOH D2004 O 175.3 100.6 85.9 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DEP RELATED DB: PDB REMARK 900 MEMBRANE PROTEIN, NMR, 1 STRUCTURE REMARK 900 RELATED ID: 2RH1 RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN B2-ADRENERGIC G PROTEIN- REMARK 900 COUPLED RECEPTOR REMARK 900 RELATED ID: 2R4R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR REMARK 900 RELATED ID: 2R4S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 3-32 AT THE N-TERMINUS AND RESIDUES 244-271 REMARK 999 AND 277-278 OF THE THIRD INTRCELLULAR LOOP WERE DELETED FROM REMARK 999 THE CONSTRUCT. THE CONSTRUCT WAS TRUNCATED AFTER RESIDUE 367 REMARK 999 AND A HEXAHIS TAG ADDED. REMARK 999 THE FOLLOWING MUTATIONS WERE MADE TO IMPROVE REMARK 999 THERMOSTABILITY R68S,M90V,Y227A,A282L,F327A,F338M THE REMARK 999 FOLLOWING MUTATIONS WERE MADE TO IMPROVE EXPRESSION AND REMARK 999 HELP CRYSTALLISATION C116L, C358A DBREF 2VT4 A 31 32 PDB 2VT4 2VT4 31 32 DBREF 2VT4 A 33 243 UNP P07700 ADRB1_MELGA 33 243 DBREF 2VT4 A 272 276 UNP P07700 ADRB1_MELGA 272 276 DBREF 2VT4 A 279 367 UNP P07700 ADRB1_MELGA 279 367 DBREF 2VT4 A 368 373 PDB 2VT4 2VT4 368 373 DBREF 2VT4 B 31 32 PDB 2VT4 2VT4 31 32 DBREF 2VT4 B 33 243 UNP P07700 ADRB1_MELGA 33 243 DBREF 2VT4 B 272 276 UNP P07700 ADRB1_MELGA 272 276 DBREF 2VT4 B 279 367 UNP P07700 ADRB1_MELGA 279 367 DBREF 2VT4 B 368 373 PDB 2VT4 2VT4 368 373 DBREF 2VT4 C 31 32 PDB 2VT4 2VT4 31 32 DBREF 2VT4 C 33 243 UNP P07700 ADRB1_MELGA 33 243 DBREF 2VT4 C 272 276 UNP P07700 ADRB1_MELGA 272 276 DBREF 2VT4 C 279 367 UNP P07700 ADRB1_MELGA 279 367 DBREF 2VT4 C 368 373 PDB 2VT4 2VT4 368 373 DBREF 2VT4 D 31 32 PDB 2VT4 2VT4 31 32 DBREF 2VT4 D 33 243 UNP P07700 ADRB1_MELGA 33 243 DBREF 2VT4 D 272 276 UNP P07700 ADRB1_MELGA 272 276 DBREF 2VT4 D 279 367 UNP P07700 ADRB1_MELGA 279 367 DBREF 2VT4 D 368 373 PDB 2VT4 2VT4 368 373 SEQADV 2VT4 SER A 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2VT4 VAL A 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2VT4 LEU A 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2VT4 ALA A 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2VT4 LEU A 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2VT4 ALA A 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2VT4 MET A 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2VT4 ALA A 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2VT4 SER B 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2VT4 VAL B 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2VT4 LEU B 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2VT4 ALA B 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2VT4 LEU B 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2VT4 ALA B 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2VT4 MET B 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2VT4 ALA B 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2VT4 SER C 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2VT4 VAL C 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2VT4 LEU C 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2VT4 ALA C 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2VT4 LEU C 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2VT4 ALA C 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2VT4 MET C 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2VT4 ALA C 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQADV 2VT4 SER D 68 UNP P07700 ARG 68 ENGINEERED MUTATION SEQADV 2VT4 VAL D 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 2VT4 LEU D 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 2VT4 ALA D 227 UNP P07700 TYR 227 ENGINEERED MUTATION SEQADV 2VT4 LEU D 282 UNP P07700 ALA 282 ENGINEERED MUTATION SEQADV 2VT4 ALA D 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 2VT4 MET D 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 2VT4 ALA D 358 UNP P07700 CYS 358 ENGINEERED MUTATION SEQRES 1 A 313 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 A 313 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 A 313 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 A 313 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 A 313 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 A 313 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 A 313 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 A 313 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 A 313 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 A 313 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 A 313 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 A 313 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 A 313 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 A 313 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 A 313 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 A 313 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 A 313 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS ARG VAL MET SEQRES 18 A 313 LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 19 A 313 ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 20 A 313 LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU VAL SEQRES 21 A 313 PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY TYR SEQRES 22 A 313 ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SER SEQRES 23 A 313 PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA PHE SEQRES 24 A 313 PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS HIS HIS SEQRES 25 A 313 HIS SEQRES 1 B 313 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 B 313 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 B 313 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 B 313 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 B 313 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 B 313 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 B 313 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 B 313 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 B 313 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 B 313 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 B 313 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 B 313 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 B 313 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 B 313 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 B 313 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 B 313 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 B 313 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS ARG VAL MET SEQRES 18 B 313 LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 19 B 313 ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 20 B 313 LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU VAL SEQRES 21 B 313 PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY TYR SEQRES 22 B 313 ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SER SEQRES 23 B 313 PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA PHE SEQRES 24 B 313 PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS HIS HIS SEQRES 25 B 313 HIS SEQRES 1 C 313 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 C 313 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 C 313 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 C 313 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 C 313 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 C 313 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 C 313 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 C 313 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 C 313 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 C 313 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 C 313 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 C 313 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 C 313 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 C 313 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 C 313 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 C 313 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 C 313 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS ARG VAL MET SEQRES 18 C 313 LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 19 C 313 ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 20 C 313 LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU VAL SEQRES 21 C 313 PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY TYR SEQRES 22 C 313 ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SER SEQRES 23 C 313 PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA PHE SEQRES 24 C 313 PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS HIS HIS SEQRES 25 C 313 HIS SEQRES 1 D 313 MET GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY SEQRES 2 D 313 MET SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL SEQRES 3 D 313 ALA GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY SER THR SEQRES 4 D 313 GLN ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER SEQRES 5 D 313 LEU ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL SEQRES 6 D 313 PRO PHE GLY ALA THR LEU VAL VAL ARG GLY THR TRP LEU SEQRES 7 D 313 TRP GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP SEQRES 8 D 313 VAL LEU CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL SEQRES 9 D 313 ILE ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE SEQRES 10 D 313 ARG TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL SEQRES 11 D 313 ILE ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER SEQRES 12 D 313 PHE LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP SEQRES 13 D 313 PRO GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS SEQRES 14 D 313 ASP PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER SEQRES 15 D 313 ILE ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE SEQRES 16 D 313 VAL ALA LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE SEQRES 17 D 313 ARG LYS ILE ASP ARG ALA SER LYS ARG LYS ARG VAL MET SEQRES 18 D 313 LEU MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 19 D 313 ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 20 D 313 LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU VAL SEQRES 21 D 313 PRO ASP TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY TYR SEQRES 22 D 313 ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SER SEQRES 23 D 313 PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA PHE SEQRES 24 D 313 PRO ARG LYS ALA ASP ARG ARG LEU HIS HIS HIS HIS HIS SEQRES 25 D 313 HIS HET P32 A 400 21 HET NA A 401 1 HET SOG A 402 20 HET SOG A 403 20 HET SOG A 405 20 HET D10 A 406 10 HET P32 B 400 21 HET NA B 401 1 HET SOG B 402 20 HET SOG B 404 10 HET SOG B 405 20 HET P32 C 400 21 HET NA C 401 1 HET SOG C 402 20 HET SOG C 404 20 HET SOG C 405 20 HET D10 C 406 10 HET P32 D 400 21 HET NA D 401 1 HET SOG D 402 20 HET SOG D 403 20 HET SOG D 405 20 HETNAM P32 4-{[(2S)-3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL]OXY}-3H- HETNAM 2 P32 INDOLE-2-CARBONITRILE HETNAM NA SODIUM ION HETNAM SOG OCTYL 1-THIO-BETA-D-GLUCOPYRANOSIDE HETNAM D10 DECANE HETSYN SOG 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5- HETSYN 2 SOG TRIOL; 1-S-OCTYL-BETA-D-THIOGLUCOSIDE; OCTYL 1-THIO- HETSYN 3 SOG BETA-D-GLUCOSIDE; OCTYL 1-THIO-D-GLUCOSIDE; OCTYL 1- HETSYN 4 SOG THIO-GLUCOSIDE FORMUL 5 P32 4(C16 H21 N3 O2) FORMUL 6 NA 4(NA 1+) FORMUL 7 SOG 12(C14 H28 O5 S) FORMUL 10 D10 2(C10 H22) FORMUL 27 HOH *31(H2 O) HELIX 1 1 TRP A 40 THR A 69 1 30 HELIX 2 2 GLN A 70 GLN A 73 5 4 HELIX 3 3 THR A 74 LEU A 93 1 20 HELIX 4 4 LEU A 93 GLY A 105 1 13 HELIX 5 5 GLY A 110 ILE A 143 1 34 HELIX 6 6 SER A 145 MET A 153 1 9 HELIX 7 7 THR A 154 MET A 179 1 26 HELIX 8 8 ASP A 186 ASP A 195 1 10 HELIX 9 9 ASN A 204 PHE A 216 1 13 HELIX 10 10 PHE A 216 GLU A 236 1 21 HELIX 11 11 ARG A 284 ASN A 316 1 33 HELIX 12 12 PRO A 321 CYS A 344 1 24 HELIX 13 13 SER A 346 LEU A 357 1 12 HELIX 14 14 GLN B 39 THR B 69 1 31 HELIX 15 15 THR B 74 LEU B 93 1 20 HELIX 16 16 LEU B 93 GLY B 105 1 13 HELIX 17 17 GLY B 110 SER B 145 1 36 HELIX 18 18 SER B 145 MET B 153 1 9 HELIX 19 19 THR B 154 PHE B 174 1 21 HELIX 20 20 PHE B 174 MET B 179 1 6 HELIX 21 21 ASP B 186 ASP B 195 1 10 HELIX 22 22 ASN B 204 PHE B 216 1 13 HELIX 23 23 PHE B 216 GLU B 236 1 21 HELIX 24 24 ARG B 284 ASN B 316 1 33 HELIX 25 25 PRO B 321 TYR B 343 1 23 HELIX 26 26 SER B 346 LEU B 357 1 12 HELIX 27 27 GLN C 39 THR C 69 1 31 HELIX 28 28 THR C 74 LEU C 93 1 20 HELIX 29 29 LEU C 93 GLY C 105 1 13 HELIX 30 30 GLY C 110 SER C 145 1 36 HELIX 31 31 SER C 145 MET C 153 1 9 HELIX 32 32 THR C 154 PHE C 174 1 21 HELIX 33 33 PHE C 174 MET C 179 1 6 HELIX 34 34 ASP C 186 ASP C 195 1 10 HELIX 35 35 ASN C 204 PHE C 216 1 13 HELIX 36 36 PHE C 216 GLU C 236 1 21 HELIX 37 37 ARG C 284 ASN C 316 1 33 HELIX 38 38 PRO C 321 TYR C 343 1 23 HELIX 39 39 CYS C 344 SER C 346 5 3 HELIX 40 40 GLU D 41 THR D 69 1 29 HELIX 41 41 GLN D 70 GLN D 73 5 4 HELIX 42 42 THR D 74 LEU D 93 1 20 HELIX 43 43 LEU D 93 GLY D 105 1 13 HELIX 44 44 GLY D 110 ILE D 143 1 34 HELIX 45 45 SER D 145 MET D 153 1 9 HELIX 46 46 THR D 154 MET D 179 1 26 HELIX 47 47 ASP D 186 ASP D 195 1 10 HELIX 48 48 ASN D 204 PHE D 216 1 13 HELIX 49 49 PHE D 216 GLU D 236 1 21 HELIX 50 50 ARG D 284 ASN D 316 1 33 HELIX 51 51 PRO D 321 CYS D 344 1 24 HELIX 52 52 SER D 346 LEU D 357 1 12 SSBOND 1 CYS A 114 CYS A 199 1555 1555 2.04 SSBOND 2 CYS A 192 CYS A 198 1555 1555 2.08 SSBOND 3 CYS B 114 CYS B 199 1555 1555 2.05 SSBOND 4 CYS B 192 CYS B 198 1555 1555 2.08 SSBOND 5 CYS C 114 CYS C 199 1555 1555 2.05 SSBOND 6 CYS C 192 CYS C 198 1555 1555 2.08 SSBOND 7 CYS D 114 CYS D 199 1555 1555 2.04 SSBOND 8 CYS D 192 CYS D 198 1555 1555 2.08 LINK O CYS A 192 NA NA A 401 1555 1555 2.47 LINK O ASP A 195 NA NA A 401 1555 1555 2.34 LINK O CYS A 198 NA NA A 401 1555 1555 2.32 LINK NA NA A 401 O HOH A2002 1555 1555 2.47 LINK NA NA A 401 O HOH A2006 1555 1555 2.47 LINK O ASP B 195 NA NA B 401 1555 1555 2.45 LINK O CYS B 198 NA NA B 401 1555 1555 2.48 LINK O ASP C 195 NA NA C 401 1555 1555 2.44 LINK O CYS C 198 NA NA C 401 1555 1555 2.47 LINK NA NA C 401 O HOH C2005 1555 1555 2.58 LINK O CYS D 192 NA NA D 401 1555 1555 2.46 LINK O ASP D 195 NA NA D 401 1555 1555 2.36 LINK O CYS D 198 NA NA D 401 1555 1555 2.30 LINK NA NA D 401 O HOH D2004 1555 1555 2.29 CRYST1 55.500 86.800 95.500 67.60 73.30 85.80 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018018 -0.001323 -0.005298 0.00000 SCALE2 0.000000 0.011552 -0.004700 0.00000 SCALE3 0.000000 0.000000 0.011803 0.00000